JANUS HENDERSON GROUP PLC

Holdings History for Xenon Pharmaceuticals Inc. - Common Stock (XENE)

Symbol: XENE on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 3,943,885 shares
Security Ownership %: 5.1%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Xenon Pharmaceuticals Inc. Common Stock (XENE)

14 Nov 2025 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,943,885 shares of Xenon Pharmaceuticals Inc. Common Stock (XENE). This represents 5.1% ownership of the company. This is the first filing by JANUS HENDERSON GROUP PLC disclosing ownership of Xenon Pharmaceuticals Inc. Common Stock (XENE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
JANUS HENDERSON GROUP PLC	5.1%		$158,346,983	3,943,885			$40.15	13G	30 Sep 2025	14 Nov 2025, 10:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.08%	+0%	$183,109,819	4,084,034	+140,149	+3.6%	$44.84	Q4 2025
30 Sep 2025	0.07%	+0.01%	$158,311,659	3,943,885	+366,150	+10%	$40.14	Q3 2025
30 Jun 2025	0.05%	+0%	$112,011,992	3,577,735	+252,642	+7.6%	$31.31	Q2 2025
31 Mar 2025	0.06%	+0.01%	$113,909,336	3,325,093	+458,338		$34.26	Q1 2025
31 Dec 2024	0.06%	+0.01%	$112,425,225	2,866,755	+314,363	+12%	$39.22	Q4 2024
30 Sep 2024	0.05%	+0.03%	$100,506,098	2,552,392	+1,507,135	+144%	$39.38	Q3 2024
30 Jun 2024	0.02%	+0%	$40,771,576	1,045,257	+103,688	+11%	$39.01	Q2 2024
31 Mar 2024	0.02%	-0%	$40,547,955	941,569	-24,496	-2.5%	$43.06	Q1 2024
31 Dec 2023	0.03%	+0.02%	$44,483,518	966,065	+583,760	+153%	$46.05	Q4 2023
30 Sep 2023	0.01%	+0%	$13,051,893	382,305	+54,961	+17%	$34.14	Q3 2023
30 Jun 2023	0.01%	+0%	$12,606,017	327,344	+5,879	+1.8%	$38.51	Q2 2023
31 Mar 2023	0.01%	+0%	$11,505,232	321,465	+29,679	+10%	$35.79	Q1 2023
31 Dec 2022	0.01%	+0%	$11,494,909	291,786	+57,952	+25%	$39.39	Q4 2022
30 Sep 2022	0.01%	-0%	$8,431,000	233,834	-42,840	-15%	$36.06	Q3 2022
30 Jun 2022	0.01%	+0.01%	$8,411,000	276,674	+266,393	+2591%	$30.40	Q2 2022
31 Mar 2022	0%	+0%	$315,000	10,281	+10,281	NEW	$30.64	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.